Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-27

Clinical Trial Update: Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for fixed-dose combination of trazodone and gabapentin in Painful Diabetic Neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trazodone/Gabapentin fixed-dose combination

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED